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Abstract: The objective of this study was to investigate the functional expression of the efflux 
transporter, P-glycoprotein (P-gp), in primary cultures of human cytotrophoblasts and BeWo cell 
monolayers. Uptake studies with primary cultures of human cytotrophoblasts or BeWo cells 
were conducted with calcein-AM and vinblastine (P-gp markers) or fluorescein (MRP marker) in 
the presence of specific P-gp or MRP inhibitors.  Results showed that the accumulation of P-gp 
substrates calcein-AM and vinblastine by BeWo cells or primary cultures of human 
cytotrophoblasts was significantly enhanced in the presence of a typical P-gp inhibitor, 
cyclosporin-A, or other inhibitors such as quinidine, verapamil and dipyridamole.  MRP inhibitors 
had no effect on the accumulation of calcein or fluorescein by BeWo cells.  Western blots 
confirmed the presence of multidrug resistant gene product 1 (MDR1) in both, primary cultures 
of human cytotrophoblasts and BeWo cells. This study demonstrates functional P-gp in term 
human trophoblasts and further supports the use of primary cultures of human cytotrophoblasts 
and BeWo cells as in vitro models of the trophoblast to investigate mechanisms regulating drug 
distribution across the placenta.  
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Introduction 
The syncytiotrophoblast layer comprises the human placental barrier and plays an 
important role in controlling the passage of blood-borne substances from mother to fetus [1]. 
The primary mechanism of transport of substances from the mother to fetus is largely 
considered to be via passive diffusion, although specific carrier-mediated processes have been 
identified [2,3]. In addition, the transcellular mechanism of drug transport across the placenta is 
possible for drugs having a lipophilic or hydrophobic nature[1-3].  
P-glycoprotein, a 170-kDa transmembrane glycoprotein (multidrug resistant gene 
product 1 or MDR1), and multidrug resistant associated protein (MRP), a 190-kDa protein, have 
been established to be active efflux mechanisms in cells from multidrug-resistant cell lines [4].   
P-gp can confer multidrug resistance by actively extruding a wide range of structurally 
unrelated, amphiphilic or hydrophobic drugs from the cell.  Most of the substrates for P-gp are 
toxic compounds of natural or semisynthetic origin [5].  P-gp is expressed in various normal 
human tissues, such as small intestine, kidney, liver,  and capillary endothelial cells of brain and 
testes [6-8]. Based on the tissue distribution, P-gp has been proposed to have a significant role 
in the protection of organisms against toxic xenobitics [9,10].    MRP is now known as a family of 
at least six distinct proteins also with polyspecific substrate efflux properties and some 
overlapping substrate specificity with P-gp [11,12].  
Immunohistochemical studies have shown that P-gp is also expressed in the placenta 
[6].  Nakamura et al. [13] using immunoblotting experiments also showed the expression of P-gp 
specifically in the human cyto- and syncytio-trophoblasts. Although P-gp in the analogous 
transporting trophoblast layer (labyrinth) is speculated to play a signficant role in the protection 
of the rodent fetus from toxic compounds [14], its function, such as transporting activity and 
substrate specificity in the human cyto- and syncytio-trophoblasts, remain unknown.  Also, 
currently no information exists regarding the presence of a functional multidrug resistant 
associated protein (MRP) in the placenta. 
The objectives of this study were to determine if P-gp and MRP expressed by human 
trophoblasts is functional by employing the in vitro systems, primary cultures of human 
cytotrophoblasts which spontaneously aggregate to form a syncytiotrophoblast, and the 
trophoblast-like BeWo cell line, which is comprised of a mix of predominantly cytotrophoblasts 
and a few syncytiotrophoblasts.  Our previous studies have described the use of both human 
cytotrophoblasts and BeWo cell monolayers to investigate normal human trophoblast transport 
and metabolism functions [3,16-19].    Demonstration of the efflux mechanism in these in vitro 
systems provides potential tools to investigate the roles and contributions trophoblast 
transporters in drug distribution across the human placenta. 
 
Materials and Methods  
Chemicals 
Calcein-AM and fluorescein were obtained from Sigma Chemicals (St Louis, MO). 3H-
vinblastine was obtained from Moravek Biochemicals (Brea, CA). All other chemicals and 
reagents were obtained from Sigma or Fisher and used without further purification.  
Utoguchi, N., Chandorkar, G.A., Avery, M., and Audus, K.L. (2000) Functional expression of P-glycoprotein in primary cultures of 
human cytotrophoblasts and BeWo cells. Reprod. Toxicol. 14, 217-224.  PMID: 10838122.  Publisher’s official version: 
<http://dx.doi.org/10.1016/S0890-6238(00)00071-X >.  Open Access version:  http://kuscholarworks.ku.edu/dspace/. 
4 
 
 
BeWo cell culture: 
The BeWo cell line was originally derived from a human choriocarcinoma [20]. The 
BeWo clone (b30) was obtained from Dr. Alan Schwartz (Washington University, St. Louis, MO).  
The cell culture protocol previously described was followed [15]. Briefly, the cells were cultured 
in Dulbecco's modified Eagle's medium containing 10% fetal bovine serum, 0.37% sodium 
bicarbonate and 1% antibiotics (10000 U/ml penicillin and 10 mg/ml streptomycin). The cells 
were maintained in 175-cm2 flasks at pH 7.4 under 5% CO2 and 95% humidity at 37°C.  The 
cells were harvested by exposure to a trypsin-EDTA solution (0.25% trypsin and 0.02% EDTA in 
Hanks' balanced salt solution) and passed onto 12-well tissue culture plates.  With the seeding 
density of 10,000 cells/cm2, the cells formed monolayers between 3 and 4 days and were used 
for experiments at that time.   
 
Primary Cultures of human cytotrophoblasts:  
The study protocol and use of human placentas in this study was approved by The 
University of Kansas Advisory Committee on Human Experimentation (ACHE #8904). Term 
placentas were obtained from unremarkable pregnancies of nonsmoking volunteers. The 
procedure for isolation and primary culture of human cytotrophoblasts was as previously 
detailed [17]. 
 
 
 
Functional expression of P-gp: 
Experiments were conducted to determine the effect of cyclosporin-A (CSA) 
concentration on the uptake of calcein-AM by BeWo cells. The BeWo cells at confluence were 
washed three times with the assay buffer of the following composition (mM): NaCl (122), 
NaHCO3 (25), KCl (3), MgSO4 (1.2), KH2PO4 (0.4), CaCl2 (1.4), D-glucose (10), Hepes (10).  
The cells were incubated with 0.5 ml of calcein-AM (1.0 µM) in the presence of CSA (0, 0.3, 1.0, 
3.0 and 10 µM) for 30 minutes at 37°C. Following incubation, the test buffer was aspirated away 
and the cells washed three times with ice cold buffer. The cells were lysed overnight with 0.5 ml 
of a 0.2 N NaOH solution that included 0.2% triton X-100. Cellular uptake of calcein-AM was 
determined by fluorescence spectroscopy (SLM Instruments Inc. Urbana, IL) at excitation and 
emission wavelengths of 488 and 530 nm, respectively. The samples were normalized for 
protein content using a BCA Protein Assay Reagent Kit (Pierce) with bovine serum albumin as 
the reference standard.  
In a separate series of experiments, cells were incubated with 0.5 ml of calcein/AM (1.0 
µM) in the presence of either a single P-gp inhibitor (10 µM CSA or 100 µM of quinidine or 
verapamil or dipyridamole) or a single MRP inhibitor (10 µM indomethacin or 100 µM of 
genistein or valproic or probenecid) for 30 minutes at 37°C.  The cells were then harvested as 
described above and assayed for accumulation of the fluorescent calcein.  
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Experiments were carried out to determine the effect of P-gp inhibitors on the 
accumulation of 3H-vinblastine, an alternative P-gp substrate, in BeWo cells using the protocol 
for Calcein-AM described above. Uptake of 3H-vinblastine (47.2 nM) by BeWo cells was studied 
in the presence of 10 µM CSA or 100 µM of quinidine or  verapamil or dipyridamole. Cellular 
uptake of 3H-vinblastine was measured by scintillation counting (Beckman Instruments) and was 
normalized for protein content.  
Uptake studies with primary cultures of human cytotrophoblasts were conducted in an 
identical fashion. Briefly, the isolated trophoblast cells were grown in 12-well plates in 
Dulbecco's modified Eagle's medium containing 20% fetal bovine serum at a seeding density of 
50,000 cells/cm2. Experiments were initiated 4-5 days post-seeding. The accumulation of 0.5 ml 
of calcein-AM (1.0 µM) or 3H-vinblastine (47 nM) was investigated in the presence of 10 µM 
CSA or 100 µM dipyridamole. Cellular uptake of calcein-AM or 3H-vinblastine was determined 
by methods described above.  
 
Functional expression of MRP:  
Fluorescein is a substrate for MRP [21] and was therefore used in these studies. Cellular 
uptake of fluorescein by BeWo cells, was determined in the presence of MRP inhibitors such as 
probenecid (100 µM), indomethacin (100 µM), genestein (10 µM) and valproic acid (100 µM). 
Following a 30 minutes pre-incubation with the inhibitors, the cells were incubated with 0.5 ml of 
fluorescein (100 µM) in the presence or absence (control group) of the inhibitors.  The 
experimental procedure was similar to the one described above. Cellular uptake of fluorescein 
was determined by fluorescence spectroscopy at excitation and emission wavelengths of 488 
and 530 nm, respectively, and normalized for protein content.  
 
 
Immunochemical characterization:  
Membrane preparations (0.5 to 10-µg placental microsome protein or 0.05-µg BeWo or 
primary trophoblast cells) were subjected to SDS-PAGE, 12% acrylamide Tris-glycine. All 
membrane samples were heated to 100°C for 10 min and centrifuged at 10,000 g for 5 min. 
Molecular weight markers (250 kDa to 4 kDa) and purified bovine serum albumin (0.5 mg) 
served as controls. Electrophoresis of microsomes with SDS-PAGE was monitored at 95 volts 
for 2.5 hr. Following electrophoresis, protein was either transferred to PVDF or polyacrylamide 
gels and exposed to Coumassie blue stain (0.1% Coumassie blue, 45% methanol, 2% acetic 
acid) for one hour. Following SDS-PAGE, membrane proteins were transferred 
electrophoretically to PVDF membranes (45 volts, 2 hr). After electrophoresis transfer, PVDF 
membranes were immersed in Ponceau S staining solution for 5 min to verify the presence of 
membrane protein. The Ponceau stain was removed in an aqueous solution containing 10% 
acetic acid (v/v) for approximately 4-5 min. To block non-specific binding of the monoclonal 
antibody (C219; Signet, Deadham, MA), membranes were incubated for two hours with 
phosphate buffered saline, pH 7.4 containing 10% dry milk (w/v), 2% bovine serum albumin 
(w/v) and 0.1% tween-20. The membranes were then incubated with monoclonal antibody to P-
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gp (10 mg/ml) or a pre-immune mouse antibody (non-specific IgG, 10 mg/ml) in 10 mM Tris-
HCl, pH 7.4, containing 0.1% tween-20. All membrane protein bound to PVDF membranes was 
incubated overnight at room temperature with the polyclonal antibody or the nonspecific IgG. A 
secondary antibody IgG peroxidase conjugate specific for the P-gp monoclonal antibody, was 
diluted 1:80,000 in 10 mM Tris-HCl containing 0.05% tween-20 and incubated with the PVDF 
membrane for one hour at 25°C. P-gp was detected by enhanced chemiluminescence by 
incubating PVDF immunoblots at 25°C for 45 sec and then exposed to Hyperfilm-ECl. 
 
Data Analysis 
Data are expressed as means ± SD for at least four replicates. The comparison between 
mean values within each experimental series was performed by one-way analysis of variance 
by using Dunnett’s test to compare several treatments against an untreated control. The 0.05 
level of probability was used as the criterion of significance.   
 
Results 
  The effect of different concentrations of CSA on the cellular uptake of calcein-AM is 
shown in Figure 1. Uptake of calcein-AM, measure by calcein accumulation, increased 
significantly (p<0.05) and in a concentration-dependent manner with increasing concentrations 
of CSA.   A 10 µM concentration of CSA resulted in the highest uptake of calcein-AM by BeWo 
cells.   The functional presence of P-gp in BeWo cells was further affirmed by studying the 
uptake of an alternative substrate, 3H-vinblastine, in the presence of selected P-gp inhibitors as 
shown in Figure 2.  The uptake of 3H-vinblastine was significantly higher in the presence of P-gp 
inhibitors such as quinidine, verapamil and dipyridamole indicating the presence of P-gp activity 
in BeWo cells.  
The uptake of calcein-AM and 3H-vinblastine by primary cultures of human 
cytotrophoblasts was investigated in the presence of two P-gp inhibitors CSA and dipyridamole 
as shown in Figures 3A and 3B, respectively. The uptake of both substrates was significantly 
enhanced (p<0.05) in the presence of the P-gp inhibitors indicating functional activity of P-gp in 
primary cultures of human cytotrophoblasts, consistent with the observations with BeWo cells.  
Both the primary cultures of human cytotrophoblasts and BeWo cells were shown to 
retain expression of MDR1.  The immunoblot shown in Figure 4 was generated with the anti-
human C219 monoclonal antibody and confirmed typical bands for protein corresponding to P-
gp from the BeWo cell line and from four different preparations of primary cultures of 
cytotrophoblasts.  
The functional expression of MRP in BeWo cells was investigated by studying the 
uptake of the MRP substrate, fluorescein, by BeWo cells in the presence of MRP inhibitors, 
genestein, valproic acid, probenecid and indomethacin.  As illustrated in Figure 5, the cellular 
uptake of fluorescein was not significantly enhanced in the presence of MRP inhibitors, 
indicating the absence of MRP in BeWo cells.  Further, data summarized in Table 1 confirmed 
that a selection of P-gp inhibitors, but not MRP inhibitors, effectively stimulated calcein 
accumulation ruling out an apparent functional MRP activity.   Therefore, these results verified 
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that the measured increase in fluorescence in our experiments with calcein/AM was due to 
impairment of P-gp-mediated efflux of calcein/AM rather than MRP-mediated efflux of the 
fluorescent calcein. 
 
Discussion  
P-glycoprotein or MDR1 is an efflux membrane pump with broad substrate specificity for 
a variety of structurally diverse chemicals.  Drugs such as the vinca alkaloids, anthracyclines, 
taxanes and cyclosporin A have been shown to be P-gp inhibitors [22].  The transporting P-gps 
are generally overexpressed in tumor cells, conferring resistance against cytotoxic agents and 
are associated with specialized normal tissue barriers (e.g., blood-brain barrier, blood-testis 
barrier, blood-ovarian barrier, placenta, gastrointestinal epithelium, etc.) [6-8].   
Although the placenta has been considered to be an inefficient barrier to drug 
distribution between maternal and fetal circulations [23], Lankas et al. [14] recently provided 
evidence of the importance of placental P-gp in a spontaneous “knockout” mice.  Their study 
suggested that the placenta may play more than a passive role in regulating chemical 
distribution and consequently, differences in blood levels of chemicals between the mother and 
fetus to the point of influencing fetal development.  Specifically, 100% of the fetuses from 
placental P-gp knockouts exhibited birth defects on chemical exposure at critical times during 
pregancy.  Fetuses from mice with normal placental P-gp expression were exposed to a 
substantially lower chemical burden and completely protected from birth defects.    Mylona et al. 
[24] have reported abundant expression of the MDR1 gene in the human placenta, particularly 
in the cytotrophoblasts throughout the course of pregnancy. An alternative mechanism, a MRP, 
also purportedly is expressed in the human placenta [25].  Therefore, the expression of the 
MDR1 gene and MRP may also provide the human placenta with potential mechanisms to 
regulate fetal exposure to drugs and chemicals.  
We report here, specific uptake studies conducted to confirm the functional activity of P-
gp in the human trophoblast using human cell culture systems.   Calcein-AM was chosen as one 
of the markers to determine P-gp activity in BeWo cells.  In the absence of P-pg influences, 
calcein-AM is a non-fluorescent, highly lipid soluble dye that can rapidly permeate the plasma 
membrane of normal cells. Once inside the cells, the ester bonds are cleaved by the 
endogenous esterases converting calcein-AM to fluorescent calcein [26].   The electronegative 
calcein generated in the cytoplasm is a substrate for MRP, not Pgp, and is retained in the cell in 
the absence of MRP [27].   The presence of CSA, a known P-gp inhibitor [28] increased the 
accumulation of calcein in BeWo cells in a concentration-dependent manner indicating 
significant P-gp activity. Accumulation of the alternative P-gp substrate, vinblastine was also 
enhanced in the presence of other known P-gp inhibitors.  
The synctiotrophoblast surrounding the chorionic villi forms the primary barrier between 
the mother and fetus. The functional expression of P-gp in the trophoblast cells was investigated 
using human cytotrobhoblasts, which fully aggregate to form a syncytiotrophoblast in primary 
culture. As seen with BeWo cells, which is a mixture of primarily cytotrophoblasts with a few 
synctiotrophoblasts [15], the uptake of P-gp substrates vinblastine and calcein-AM by the 
primary cultures, was also significantly enhanced in the presence of other P-gp inhibitors.  The 
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biochemical evidence for the presence of P-gp in BeWo cells and the primary cultures was 
confirmed by immunoblotting experiments. The C219 monoclonal antibody used in these 
experiments is specific for MDR1 [29,30] and the positive findings were in good agreement with 
the literature [24,31] for normal human trophoblasts. 
The presence of MRP-like activity in BeWo cells was investigated using fluorescein as a 
substrate.    Fluorescein has been used previously as a marker for similar types studies [21]. 
However, the presence of MRP inhibitors such as valproic acid, genestein, probenecid and 
indomethacin, did not result in significant increase in fluorescein accumulation.   As described 
above, calcein-AM is a substrate for P-gp and calcein a substrate for MRP [27].  In our studies, 
only the P-gp inhibitors, and not the MRP inhibitors, stimulated accumulation of calcein and 
further confirmed the fluorescein study results.  Our studies were consistent with the findings of 
Sugawara et al. [32] who have shown that MRP is not expressed in the placenta and in contrast 
to Flens et al [25] who suggested the presence of MRP in human placenta.   We have not yet 
performed immunoblots for MRP which may show expression of a protein that was not active in 
our study.   The possible presence of multiple isoforms of MRP [11,12] in the trophoblasts 
creates a more complex investigation and will have to be considered in future studies.  
In summary, this study reports the functional expression of P-gp in the BeWo cell 
monolayers and primary cultures of human cytotrophoblasts, in vitro systems representing the 
human trophoblast.  The results further emphasize some of the biochemical similarities of the 
BeWo cells and the primary cultures of normal human cytotrophoblasts and affirm the use of the 
cell line for some investigations of trans-trophoblast transport of nutrients and drugs.   Recent 
reports suggest that endogenous steroids including the hormone of pregnancy, progesterone, 
may regulate P-gp function [33].   Therefore, our results will form the basis for further 
investigation of the role of efflux systems in regulating the distribution of endogenous steroids 
and xenobiotics across the placenta, and their possible role in regulating P-gp function in the 
human trophoblast.   
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 Figures Legends 
  
FIG. 1. Calcein-AM (1 µM) accumulation in BeWo cells following exposure to indicated 
concentrations of cyclosporin A.  Data points represent the mean ± SD from at least four 
different BeWo monolayers.  * p < 0.001 compared to control .   
 
FIG. 2.  Cellular accumulation of 3H-vinblastine in BeWo cells in the presence of 
cyclosporin A (CSA, 10 µM), quinidine (QUIN, 100 µM), verapamil (VER, 100 µM) or 
dipyridamole (DPM, 100 µM).  Data points represent the mean ± SD from at least four 
different BeWo monolayers. 
* p < 0.05, ** p < 0.001 compared to control.   
 
FIG. 3.  Effects of P-gp inhibitors on calcein-AM or 3H-vinblastine accumulation by 
primary cultured human trophoblasts. Cells were incubated with calcein-AM (A) or 3H-
vinblastine (B) for 30 min in the absence or presence of P-gp inhibitors.  CSA; 
cyclosporin A (10 µM), DPM; dipyridamole (100 µM).  Data points represent the mean ± 
SD from at least four different primary cultures human cytotrophoblasts monolayers.   * 
p < 0.05, ** p < 0.01, ***  p < 0.001compared to control. 
 
FIG 4.  Immunoprecipitation /Western blot of BeWo cell protein (lane 1) and four different 
preparations of primary cultures of human cytotrophoblasts (lanes 2-5) generated with the anti-
human C219 antibody. 
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FIG. 5.  Effects of MRP inhibitors on fluorescein accumulation in BeWo cells.  BeWo cells were 
treated with genistein (GEN, 100 µM), valproic acid (VPA, 100 µM), probenecid (PRB, 100 µM) 
or indomethacin (IND, 10 µM).  Data points represent the mean ± SD from at least four different 
BeWo monolayers. 
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Table 1.  Effect of P-glycoprotein (P-gp) or multidrug resistance-associated protein (MRP) 
inhibitors on the accumulation of calcein-AM by BeWo cells. 
Target Efflux 
Mechanism 
Efflux 
Inhibitor 
Concentration of 
Inhibitor (µM) 
Relative Accumulation 
(% of Untreated Control) 
P-gp Cyclosporin A 10 218 ± 46 * 
 Quinidine 100 153 ± 40 * 
 Verapamil 100 212 ± 35 * 
 Dipyridamole 100 215 ± 49 * 
    
MRP Genistein 100 94 ± 11 
 Valproic acid 100 96 ±   4 
 Probenecid 100 91 ± 15 
 Indomethacin 10 93 ± 10 
* raw data significantly different (p < 0.001) from calcein-AM uptake in the absence of an 
inhibitor (Control) 
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Figure 3: Utoguchi et al.
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Figure 4: Utoguchi et al.  
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